ClinicalTrials.Veeva

Menu

Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke (PURE)

Merz Pharmaceuticals logo

Merz Pharmaceuticals

Status and phase

Completed
Phase 3

Conditions

Post-stroke Spasticity of the Upper Limb

Treatments

Drug: IncobotulinumtoxinA (400 Units)
Drug: Placebo Comparator

Study type

Interventional

Funder types

Industry

Identifiers

NCT01392300
2010-023043-15 (EudraCT Number)
MRZ 60201/SP/3001

Details and patient eligibility

About

The purpose of this study is to determine whether injections of Botulinum toxin type A into muscles of the upper limb are effective in treating spasticity in patients after stroke.

Full description

The study consists of a randomized, double-blind, placebo-controlled, parallel-group, single-dose main period followed by an open-label, non-controlled, repeated-dose extension period (Open-Label Extension Period - OLEX).

Enrollment

317 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Upper limb spasticity
  • Time since stroke greater than 3 months
  • Need for 400 U Botulinum toxin type A

Exclusion criteria

  • Body weight below 50kg
  • Fixed contractures of the upper limb
  • Generalized disorders of muscle activity like Myasthenia gravis that preclude use of Botulinum toxin Type A
  • Infection at the injection site

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

317 participants in 2 patient groups, including a placebo group

DB IncobotulinumtoxinA (Xeomin) (400 U)
Experimental group
Description:
IncobotulinumtoxinA (Xeomin) (400 Units): Main period, one injection session - double-blind (DB), randomized treatment assignment
Treatment:
Drug: IncobotulinumtoxinA (400 Units)
DB Placebo Comparator
Placebo Comparator group
Description:
Placebo to incobotulinumtoxinA (Xeomin) (400 Units): Main period, one injection session - double-blind (DB), randomized treatment assignment
Treatment:
Drug: Placebo Comparator

Trial contacts and locations

47

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems